In this chapter, Dr. Benjamin explains that he worked in collaboration with Interventional Radiology to develop a technique for the intra-arterial delivery of Cisplatin to treat osteosarcoma: this became the standard of care at MD Anderson and at least one other institution. Dr. Benjamin explains the goals of the treatment of osteosarcoma treatments based on the fact that patients die of lung metastasis.https://openworks.mdanderson.org/mchv_interviewchapters/1546/thumbnail.jp
Charles Forscher,1 Monica Mita,2 Robert Figlin3 1Sarcoma Program, Samuel Oschin Comprehensive Cancer...
Osteosarcoma, a bone cancer most commonly seen in adolescents and young adults, is usually a high-gr...
International audienceIntroduction: Osteosarcomas are the main malignant primary bone tumours found ...
In this chapter, Dr. Benjamin talks about his research focus on sarcoma treatments, neoadjuvant ther...
In this chapter, Dr. Benjamin explains that he spent his first two years at MD Anderson establishing...
Sarcomas are rare, mesenchymal tumors of the soft tissue and bone that exhibit a marked heterogeneit...
Cautious Approach to Soft Tissue Sarcoma Yields More Favorable Outcomes What\u27s to Eat? Encourag...
Survival of bone sarcoma patients has markedly improved during the last 20 years. This was followed ...
Osteosarcoma (OS) is a class of cancer originating from bone, mainly afflicting children or young ad...
In this chapter, Dr. Benjamin gives an overview of his work with limb salvage treatments, based on t...
In this segment, Dr. Rodriguez describes studies she conducted on lymphoma treatments in collaborati...
While surgery remains the cornerstone of treatment of bone and soft tissue sarcomas, chemotherapy ha...
In this chapter, Dr. Benjamin explains how he first took an assistant professorship at the Universit...
Osteosarcoma is the most frequent malignant primary bone tumor characterized by a high potency to fo...
Osteosarcoma is the most common primary malignant tumour of bone. Currently, despite treatment with ...
Charles Forscher,1 Monica Mita,2 Robert Figlin3 1Sarcoma Program, Samuel Oschin Comprehensive Cancer...
Osteosarcoma, a bone cancer most commonly seen in adolescents and young adults, is usually a high-gr...
International audienceIntroduction: Osteosarcomas are the main malignant primary bone tumours found ...
In this chapter, Dr. Benjamin talks about his research focus on sarcoma treatments, neoadjuvant ther...
In this chapter, Dr. Benjamin explains that he spent his first two years at MD Anderson establishing...
Sarcomas are rare, mesenchymal tumors of the soft tissue and bone that exhibit a marked heterogeneit...
Cautious Approach to Soft Tissue Sarcoma Yields More Favorable Outcomes What\u27s to Eat? Encourag...
Survival of bone sarcoma patients has markedly improved during the last 20 years. This was followed ...
Osteosarcoma (OS) is a class of cancer originating from bone, mainly afflicting children or young ad...
In this chapter, Dr. Benjamin gives an overview of his work with limb salvage treatments, based on t...
In this segment, Dr. Rodriguez describes studies she conducted on lymphoma treatments in collaborati...
While surgery remains the cornerstone of treatment of bone and soft tissue sarcomas, chemotherapy ha...
In this chapter, Dr. Benjamin explains how he first took an assistant professorship at the Universit...
Osteosarcoma is the most frequent malignant primary bone tumor characterized by a high potency to fo...
Osteosarcoma is the most common primary malignant tumour of bone. Currently, despite treatment with ...
Charles Forscher,1 Monica Mita,2 Robert Figlin3 1Sarcoma Program, Samuel Oschin Comprehensive Cancer...
Osteosarcoma, a bone cancer most commonly seen in adolescents and young adults, is usually a high-gr...
International audienceIntroduction: Osteosarcomas are the main malignant primary bone tumours found ...